You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Sarcoma

Trabectedin for the treatment of advanced soft tissue sarcoma

  • Technology appraisal guidance
  • Reference number: TA185
  • Published:  24 February 2010
  • Last updated:  08 February 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Appraisal Committee members and NICE project team
  • 8 Sources of evidence considered by the Committee
  • Update information

6 Recommendations for further research

6.1

The Committee recommends that a study estimating utilities using directly observed health-related quality of life values (such as EQ−5D scores) in people with soft tissue sarcoma is conducted.


Next page 7 Appraisal Committee members and NICE project team Previous page 5 Implementation
Back to top